Harper Molly bought CPRX
December 8, 2025 · Form 4 insider transaction
Harper Molly bought 1,413 shares of Catalyst Pharmaceuticals Inc, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,413
Price
N/A
Total value
N/A
InsiderHarper Molly
Role—
SecurityCommon Stock, par value $0.001 per share
Transaction codeM: Option exercise
Transaction dateDecember 8, 2025
Filing dateDecember 10, 2025
Shares owned after9,106
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.